Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (Sirolimus)

This study has been terminated.
(On May 30, 2014, study injections were discontinued at the request of the DSMC. No further recruitment will occur.)
The EMMES Corporation
Santen Inc.
Information provided by (Responsible Party):
National Eye Institute (NEI) Identifier:
First received: August 28, 2012
Last updated: December 8, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2016
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)